Drugs / T roleandomycin

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) TAO 1969-05-27 fda.gov

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT02099240 Comparator Mar 2014 → Nov 2018 osteomyelitis University of Louisville Terminated No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as T roleandomycin T roleandomycinNCT02099240
Known as Acetyloleandomycin ChEMBL registry synonym — accepted as the source's own label CHEMBL564085
Known as NSC-108166 ChEMBL registry synonym — accepted as the source's own label CHEMBL564085
Known as Oleandomycin (as troleandomycin) ChEMBL registry synonym — accepted as the source's own label CHEMBL564085
Known as Oleandomycin triacetate ester ChEMBL registry synonym — accepted as the source's own label CHEMBL564085
Known as Triacetyloleandomycin ChEMBL registry synonym — accepted as the source's own label CHEMBL564085
Known as Troleandomicina ChEMBL registry synonym — accepted as the source's own label CHEMBL564085
Known as Troleandomycine ChEMBL registry synonym — accepted as the source's own label CHEMBL564085
Modality Small molecule CHEMBL564085